Insiders / Friedman Paul a / Activity
Activity — Friedman Paul a
34 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jan 9, 2026 | Exercise | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $4.4K | +280 +0.15% | 187,444 0.81% of shares | low |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $21.8K | -40 -0.02% | 187,164 0.81% of shares | low |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $42.6K | -80 -0.04% | 189,804 0.82% of shares | low |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $43.0K | -80 -0.04% | 188,284 0.81% of shares | low |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $79.2K | -148 -0.08% | 189,324 0.82% of shares | low |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $87.9K | -166 -0.09% | 190,164 0.82% of shares | low |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $148.6K | -280 -0.15% | 189,884 0.82% of shares | medium |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $154.3K | -280 -0.15% | 187,164 0.81% of shares | medium |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $177.3K | -332 -0.17% | 189,472 0.82% of shares | medium |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $253.5K | -473 -0.25% | 188,851 0.82% of shares | medium |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $258.8K | -480 -0.25% | 187,804 0.81% of shares | medium |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $261.5K | -487 -0.26% | 188,364 0.82% of shares | medium |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $303.7K | -575 -0.30% | 191,021 0.83% of shares | medium |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $324.2K | -600 -0.32% | 187,204 0.81% of shares | medium |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $354.8K | -681 -0.34% | 199,663 0.86% of shares | medium |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $365.7K | -691 -0.36% | 190,330 0.82% of shares | medium |
| Jan 9, 2026 | Exercise | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $387.4K | +25K +13.10% | 211,684 0.92% of shares | low |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $395.9K | -766 -0.37% | 205,003 0.89% of shares | medium |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $438.5K | -840 -0.42% | 198,823 0.86% of shares | medium |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $439.8K | -846 -0.42% | 200,344 0.87% of shares | medium |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $507.3K | -970 -0.49% | 197,853 0.86% of shares | medium |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $560.7K | -1K -0.55% | 193,156 0.84% of shares | medium |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $561.3K | -1K -0.52% | 209,110 0.91% of shares | medium |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $628.4K | -1K -0.61% | 196,654 0.85% of shares | medium |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $692.2K | -1K -0.64% | 207,765 0.90% of shares | medium |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $707.0K | -1K -0.67% | 201,190 0.87% of shares | medium |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $757.7K | -1K -0.70% | 210,204 0.91% of shares | medium |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $822.1K | -2K -0.81% | 191,596 0.83% of shares | medium |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $1.03M | -2K -0.96% | 205,769 0.89% of shares | medium |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $1.27M | -2K -1.20% | 202,553 0.88% of shares | medium |
| Jan 9, 2026 | Sell | MDGL Madrigal Pharmaceuticals, Inc. Common Stock | $1.28M | -2K -1.24% | 194,222 0.84% of shares | medium |
| Jun 9, 2026 | Grant | PRLD Prelude Therapeutics Incorporated Director Stock Option (Right to Buy) | — | +38K | 38,000 0.05% of shares | low |
| Jan 9, 2026 | Exercise | MDGL Madrigal Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | -280 -100.00% | 0 0.00% of shares | low |
| Jan 9, 2026 | Exercise | MDGL Madrigal Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | -25K -98.87% | 280 <0.01% of shares | low |